Results 121 to 130 of about 14,017 (290)
Evaluation of illicit drug contaminants in seized cannabis in Arizona and California, 2023–2024
Journal of Forensic Sciences, EarlyView.Abstract Despite public health concerns, fentanyl, cocaine, and other illicit drug contaminants remain largely understudied in unregulated cannabis. Here, we developed an analytical method to quantify a panel of common illicit drugs in cannabis and tested the law enforcement seizures in Arizona and California in evaluation of the illicit drug ...
Beckner Andersano +3 more
wiley +1 more source
Exploring the Materiality of Data Breach Disclosures on the Australian Stock Exchange
Abacus, EarlyView.This study examines Australian Stock Exchange (ASX) data breach announcements to provide insights into the extent and nature of data breach disclosures, as well as the costs, particularly to stakeholder relationships. Using a dataset of all data breach‐related announcements on the ASX, we identify a lack of data breach disclosure and, where disclosures
Jane Andrew +3 more
wiley +1 more source
Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen +7 more
wiley +1 more source
Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark +2 more
wiley +1 more source
Revistas Argentina de Medicina, 2017 Introducción. El uso de cannabis medicinal es una práctica popular en Argentina entre los pacientes que reciben cuidados paliativos, aun cuando no reciben prescripción médica para tal fin. Materiales y métodos.
Ariel Fabián Cherro +2 more
doaj +2 more sources
'Momentous achievement': Campaigners welcome confirmation of government medicinal cannabis supplier.
, 2019 Health Minister Simon Harris will bring proposals about the cannabis access programme to Cabinet next ...
Finn, Christina
core
Viabilidad del Cannabis medicinal en el contexto del turismo del Valle del Cauca
Ilustraciones y gráficos a colorGracias a los beneficios médicos comprobados por medio de investigaciones científicas, las opiniones en relación con el uso del cannabis medicinal en tratamientos de ciertas enfermedades y trastornos son cada vez más ...
Torres Mendoza Erika Tatiana
core +1 more source
, 2023 Nabbi nace con la idea de un proyecto de emprendimiento, con fines académicos, cuyo fin está en la comercialización nacional de productos para el cuidado y bienestar personal a base de Cannabidiol (CBD), que se diferencie de las otras propuestas del mercado por su fuerte sentido de responsabilidad social y medio ambiental, así como por el origen de sus
openaire +1 more source
From farm to bedside: Potential of medical cannabis in global health
Complementary Therapies in MedicineIntroduction: The growing opioid crisis and persistent global health disparities underscore the urgent need for alternative therapeutic strategies.
Maureen Bilinga Tendwa +26 more
doaj +1 more source
Bill to legalise medicinal cannabis shouldn't be passed - health committee.
, 2017 Health committee member Kate O’Connell said that an opportunity was lost to make cannabis a medical product..........
Ni Aodha, Grainne
core